Immunology/Inflammation
Read More about this categoryShow Less
The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.
Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].
BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].
Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.
Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].
References
[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.
[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.
[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.
[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.
[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.
[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.
[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.
[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.
Research Areas
- 5-Lipoxygenase(17)
- Apoptosis(675)
- Cyclic GMP-AMP Synthase(6)
- TLR(121)
- Papain(1)
- PGDS(1)
- PGE synthase(26)
- SIKs(12)
- IκB/IKK(68)
- AP-1(11)
- KEAP1-Nrf2(56)
- NOD1(1)
- NF-κB(304)
- Interleukin Related(263)
- 15-lipoxygenase(2)
- Others(10)
- Aryl Hydrocarbon Receptor(40)
- CD73(15)
- Complement System(69)
- Galectin(12)
- IFNAR(54)
- NO Synthase(93)
- NOD-like Receptor (NLR)(66)
- STING(118)
- Reactive Oxygen Species(505)
- FKBP(15)
- eNOS(4)
- iNOS(29)
- nNOS(20)
- Glutathione(54)
- Adaptive Immunity(210)
- Allergy(118)
- Arthritis(34)
- Autoimmunity(181)
- Gastric Disease(94)
- Immunosuppressants(38)
- Immunotherapeutics(4)
- Innate Immunity(566)
- Pulmonary Diseases(109)
- Reactive Nitrogen Species(50)
- Specialized Pro-Resolving Mediators(49)
- Reactive Sulfur Species(28)
- BCL6(5)
- CD20(10)
- CD22
- CD28(3)
- PSMA(12)
- FAP(16)
- Nuclear Factor of activated T Cells (NFAT)(2)
- Glycoprotein VI(2)
- Tim3(3)
- Hapten(1)
- Nectin-4(2)
- DOCK(1)
- MHC(9)
- Transmembrane Glycoprotein(17)
- TREM receptor(9)
- Inflammation or Immune System Disease(2)
- Musculoskeletal and Skin Disease(1)
- Fc Receptor (FcR)(11)
- IKZF Family(4)
- C-type Lectin-like Receptors (CTLRs)(3)
- Asialoglycoprotein Receptor (ASGPR)(3)
- Human leukocyte immunoglobulin (Ig)-like receptors (LILR)(1)
Products Related to Immunology/Inflammation(4435)
- GC11745S-(2-aminoethyl) Isothiourea (dihydrobromide)CAS: 56-10-0Purity: >98%
non-selective inhibitor of all NOS isoforms
- GC11751QNZ (EVP4593)CAS: 545380-34-5Purity: >98.00%
QNZ (EVP4593) is a highly potent and selective inhibitor of the nuclear factor κB (NF-κB) signaling pathway with an IC 50 value of 11nM and has anti-inflammatory effects.
- GC11770Ketone EsterCAS: 1208313-97-6Purity: >99.50%
A ketone ester with anti-obesity and anticonvulsant activities
- GC11786AcetylcysteineCAS: 616-91-1Purity: >99.00%
Acetylcysteine هو مشتق N-acetyl من L-cysteine وسابق لـglutathione وله نشاط مذيب للبلغم.
- GC11800SB 290157 (trifluoroacetate salt)CAS: 1140525-25-2Purity: >99.50%
SB 290157 (ملح ثلاثي فلورو أسيتات) هو مناهض قوي وانتقائي لمستقبلات C3a مع IC 50 من 200 نانومتر.
- GC11866Cyclosporin DCAS: 63775-96-2Purity: >98%
السيكلوسبورين د ، مستقلب للسيكلوسبورين أ ، هو مثبط مناعي ضعيف
- GC11867(S)-LisofyllineCAS: 100324-80-9Purity: >98%
inactive optical enantiomer of (R)-LSF, an anti-inflammatory agent
- GC12232BAY-X 1005CAS: 128253-31-6Purity: >98.50%
BAY-X 1005 (BAY X 1005 ؛ DG-031) هو مثبط نشط للبروتين النشط عن طريق الفم وانتقائي من 5 ليبوكسجيناز (FLAP).
- GC12277MK 886CAS: 118414-82-7Purity: >99.50%
MK 886 (L 663536) هو مثبط قوي ، نافذ للخلايا ونشط عن طريق الفم (IC50 من 30 نانومتر) والتخليق الحيوي الليكوترين (IC50s من 3 نانومتر و 1.1 ميكرومتر في الكريات البيض السليمة والدم البشري الكامل ، على التوالي). MK 886 هو أيضًا مضاد PPARα غير تنافسي ويمكن أن يحفز موت الخلايا المبرمج.
- GC12288GSK-J1 sodium saltCAS: 1797832-71-3Purity: >98%
A neuropeptide with diverse biological activities
- GC123097-NitroindazoleCAS: 2942-42-9Purity: >98%
7-نيترويندازول هو مثبط انتقائي لـ nNOS له تأثيرات مضادة للألم والأوعية الدموية
- GC12342NDT 9513727CAS: 439571-48-9Purity: >99.00%
NDT 9513727 هو ناهض عكسي قوي وانتقائي وفعال عن طريق الفم وتنافسي لمستقبل C5aR البشري (مستقبل C5a) ، مع IC50 يبلغ 11.6 نانومتر
- GC12370IKK-16 (hydrochloride)CAS: 1186195-62-9Purity: >98%
IKK-16 (هيدروكلوريد) هو مثبط انتقائي IκB كيناز (IKK) لمركب IKK2 و IKK و IKK1 مع IC50s من 40 نانومتر و 70 نانومتر و 200 نانومتر ، على التوالي.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC11745 | S-(2-aminoethyl) Isothiourea (dihydrobromide) | 56-10-0 | >98% | |
non-selective inhibitor of all NOS isoforms | ||||
| GC11751 | QNZ (EVP4593) | 545380-34-5 | >98.00% | |
QNZ (EVP4593) is a highly potent and selective inhibitor of the nuclear factor κB (NF-κB) signaling pathway with an IC 50 value of 11nM and has anti-inflammatory effects. | ||||
| GC11770 | Ketone Ester | 1208313-97-6 | >99.50% | |
A ketone ester with anti-obesity and anticonvulsant activities | ||||
| GC11786 | Acetylcysteine | 616-91-1 | >99.00% | |
Acetylcysteine هو مشتق N-acetyl من L-cysteine وسابق لـglutathione وله نشاط مذيب للبلغم. | ||||
| GC11800 | SB 290157 (trifluoroacetate salt) | 1140525-25-2 | >99.50% | |
SB 290157 (ملح ثلاثي فلورو أسيتات) هو مناهض قوي وانتقائي لمستقبلات C3a مع IC 50 من 200 نانومتر. | ||||
| GC11817 | PDM 2 | 688348-25-6 | >98.50% | |
PDM 2 هو مضاد لمستقبلات أريل الهيدروكربونية (AhR) الانتقائي عالي التقارب مع Ki 1.2 ± 0.4 نانومتر. | ||||
| GC11866 | Cyclosporin D | 63775-96-2 | >98% | |
السيكلوسبورين د ، مستقلب للسيكلوسبورين أ ، هو مثبط مناعي ضعيف | ||||
| GC11867 | (S)-Lisofylline | 100324-80-9 | >98% | |
inactive optical enantiomer of (R)-LSF, an anti-inflammatory agent | ||||
| GC12040 | L-Kynurenine | 2922-83-0 | >98.00% | |
L-Kynurenine هو مستقلب للحمض الأميني L-tryptophan | ||||
| GC12070 | Ascorbic acid (Standard) | 50-81-7 | >98.00% | |
مانح إلكترونات | ||||
| GC12114 | Oxaprozin | 21256-18-8 | >99.50% | |
Oxaprozin هو مثبط فعال وفعال عن طريق الفم COX ، بقيم IC50 تبلغ 2.2 ميكرومتر للصفائح البشرية COX-1 و 36 ميكرومتر للخلية الزليلية البشرية المحفزة IL-1 COX-2 ، على التوالي | ||||
| GC12159 | HZ52 | 1077626-51-7 | >98% | |
HZ52 هو مثبط فعال للانعكاس 5-ليبوكسيجيناز ، يمنع تخليق الليكوترين مع IC50 من 0.7 ميكرومتر في كريات الدم البيضاء البشرية السليمة متعددة الأشكال | ||||
| GC12166 | 2-Iminopiperidine hydrochloride | 16011-96-4 | >98% | |
iNOS inhibitor | ||||
| GC12203 | L-Glutathione Reduced | 70-18-8 | >97.00% | |
تستخدم لإزالة GST من جيل الجلوتاثيون | ||||
| GC12205 | PD 146176 | 4079-26-9 | >98.00% | |
PD 146176 (NSC168807) ، مثبط 15-Lipoxygenase (15-LO) ، يمنع الأرانب الشبكية 15-LO (Ki \u003d 197 نانومتر ، IC50 \u003d 0.54 ميكرومتر). | ||||
| GC12232 | BAY-X 1005 | 128253-31-6 | >98.50% | |
BAY-X 1005 (BAY X 1005 ؛ DG-031) هو مثبط نشط للبروتين النشط عن طريق الفم وانتقائي من 5 ليبوكسجيناز (FLAP). | ||||
| GC12277 | MK 886 | 118414-82-7 | >99.50% | |
MK 886 (L 663536) هو مثبط قوي ، نافذ للخلايا ونشط عن طريق الفم (IC50 من 30 نانومتر) والتخليق الحيوي الليكوترين (IC50s من 3 نانومتر و 1.1 ميكرومتر في الكريات البيض السليمة والدم البشري الكامل ، على التوالي). MK 886 هو أيضًا مضاد PPARα غير تنافسي ويمكن أن يحفز موت الخلايا المبرمج. | ||||
| GC12288 | GSK-J1 sodium salt | 1797832-71-3 | >98% | |
A neuropeptide with diverse biological activities | ||||
| GC12309 | 7-Nitroindazole | 2942-42-9 | >98% | |
7-نيترويندازول هو مثبط انتقائي لـ nNOS له تأثيرات مضادة للألم والأوعية الدموية | ||||
| GC12325 | BYK 191023 dihydrochloride | 1216722-25-6 | >98% | |
INOS inhibitor,potent and selective | ||||
| GC12330 | SAR191801 | 1234708-04-3 | >99.50% | |
SAR191801 هو مثبط hPGDS ، مع IC50 لـ 12 نانومتر في مقايسة الاستقطاب الفلوري أو مقايسة EIA. | ||||
| GC12331 | JC-1 | 3520-43-2 | >99.50% | |
JC-1 (CBIC2) هو صبغة فلورية سيانين كربونيل مؤكسدة موجبة الشحنة. | ||||
| GC12342 | NDT 9513727 | 439571-48-9 | >99.00% | |
NDT 9513727 هو ناهض عكسي قوي وانتقائي وفعال عن طريق الفم وتنافسي لمستقبل C5aR البشري (مستقبل C5a) ، مع IC50 يبلغ 11.6 نانومتر | ||||
| GC12370 | IKK-16 (hydrochloride) | 1186195-62-9 | >98% | |
IKK-16 (هيدروكلوريد) هو مثبط انتقائي IκB كيناز (IKK) لمركب IKK2 و IKK و IKK1 مع IC50s من 40 نانومتر و 70 نانومتر و 200 نانومتر ، على التوالي. | ||||
